eXoZymes, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EXOZ | NRX.V | XCUR | EXPRS2.ST | XBIT | MBX.TO | |
|---|---|---|---|---|---|---|
| Market cap | 40.10M | 44.18M | 6.50M | 39.47M | 59.45M | 39.72M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -5.8 | -1.3 | 0.0 | 15.0 | 14.5 |
| Price/book | 10.9 | 26.3 | 6.5 | 0.6 | 0.5 | 1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −64.81% | −29.58% | −75.37% | −93.71% | −6.13% | +20.00% |
| Today | −9.26% | −4.00% | −1.71% | 0.00% | −2.01% | −3.33% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All EXOZ news ›MacroGenics (MGNX) director Kuriakose received 44,000 Stock Option (right to buy)
Director Emil granted 44,000 stock options at $2.40 strike and 7,500 RSUs; routine director compensation, no open-market buy. Plus members following MGNX got this by push and email at 16:32:31 ET - 0.9s after publication. Emil Kuriakose…
NurExone Biologic Demonstrates Scalable Exosome Production With Two Bioreactors
NurExone Biologic (NRX.V,NRXBF) announced that it doubled exosome production by operating two bioreactors in parallel without increasing overall manufacturing time. The process maintained consistency and comparable exosome quality, marking…
Nurexone Biologic Inc Demonstrates Scalable Exosome Production and Supports Modular Manufacturing Strategy
NurExone Biologic Inc. announced that it doubled exosome production by successfully operating two bioreactors in parallel, while maintaining the same overall production time, process consistency and... Biotechnology & Medical Research…
Why eXoZymes Is Standing Out to Investor James Tissot
Many biotech investments come down to a concentrated bet that Wall Street has become all too familiar with: the reliance on a single lead asset within a narrow development pipeline. Investors often accept long stretches between catalysts…
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
A team led by scientists at the Department of Energy's Oak Ridge National Laboratory identified and successfully demonstrated a new method to process a plant-based material called nanocellulose that reduced energy needs by a whopping 21%.…
eXoZymes (NASDAQ:EXOZ) & Allogene Therapeutics (NASDAQ:ALLO) Head-To-Head Survey
Posted by Mitch Edgeman on Oct 23rd, 2026 eXoZymes (NASDAQ:EXOZ – Get Free Report) and Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two…
Mogotes Metals Announces Grant of Options
Hyperscale Data Reaffirms 2027 Guidance of $300 Million to $350 Million in Revenue and $60 Million to $80 Million in Adjusted EBITDA Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials…
Exozymes grants director Lalonde 10,000 stock options
eXoZymes Inc. (EXOZ) develops AI-enhanced, cell-free biomanufacturing using exozymes to turn sustainable feedstock into chemicals, nutraceuticals, and medicines. Exozymes grants director Lalonde 10,000 stock options The options expire on…
Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions
16 Apr, 2024, 17:00 CST By combining Kinetics' robust portfolio and expertise with its own, Exyte further solidifies its position as a leading provider of complex solutions for the biopharma, semiconductor, and high-tech sectors. This…
NuSynth to build chemical process innovation platform with new capital
NuSynth Technologies is developing a platform to redesign chemical processes, with a focus on cost efficiency, yield, cycle time, safety, sustainability and scalability. NuSynth addresses this through process redesign based on first…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net7
- prnewswire.com2
- expresspharma.in1
- ibtimes.com1
- marketscreener.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.